Studies suggest that the germline BRIP1 mutations can be considered as a moderate risk for ovarian cancer [166–168], and prophylactic surgery is taken into consideration for patients carrying BRIP1 mutation [165, 169]. Here, BRIP1 is linked to ovarian carcinoma.